Last $1.14 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

tong ren tang technologies-h (TGRNF) Snapshot

Open
--
Previous Close
$1.14
Day High
--
Day Low
--
52 Week High
03/13/14 - $1.72
52 Week Low
12/17/14 - $1.14
Market Cap
1.6B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
628.7M
EX-Date
06/17/14
P/E TM
--
Dividend
$0.13
Dividend Yield
1.76%
Current Stock Chart for TONG REN TANG TECHNOLOGIES-H (TGRNF)

Related News

No related news articles were found.

tong ren tang technologies-h (TGRNF) Related Businessweek News

No Related Businessweek News Found

tong ren tang technologies-h (TGRNF) Details

Tong Ren Tang Technologies Co., Ltd., together with its subsidiaries, produces and distributes Chinese medicines in Mainland China and Hong Kong. The company manufactures its products in the forms of granules, water-honeyed pills, tablets, soft capsules, and liquid. It is also involved in the purchase, processing, and sale of Chinese medicinal raw materials and agricultural by-products; production of ointments; and the medical research and development activities. In addition, the company is engaged in the production, distribution, and wholesale and retail sale of healthcare products; technological development and sale of biological products, Chinese and western medicines, and cosmetics; and sale of medicinal products, as well as provision of Chinese medicine consultation and treatment services. The company was incorporated in 2000 and is based in Beijing, the People’s Republic of China. Tong Ren Tang Technologies Co., Ltd. is a subsidiary of Beijing Tong Ren Tang Company Limited.

3,318 Employees
Last Reported Date: 08/27/14
Founded in 2000

tong ren tang technologies-h (TGRNF) Top Compensated Officers

General Manager and Executive Director
Total Annual Compensation: CNY2.0M
Executive Director
Total Annual Compensation: --
Vice Chairman
Total Annual Compensation: --
Chief Accountant and Executive Director
Total Annual Compensation: CNY759.0K
Employee Representative Supervisor
Total Annual Compensation: CNY1.1M
Compensation as of Fiscal Year 2013.

tong ren tang technologies-h (TGRNF) Key Developments

Tong Ren Tang Technologies Co. Ltd. Announces Unaudited Group Earnings Results for the Nine Months Ended September 30, 2014

Tong Ren Tang Technologies Co. Ltd. announced unaudited group earnings results for the nine months ended September 30, 2014. The group recorded unaudited operating revenue of approximately RMB 2,585.82 million, unaudited net profits attributable to the shareholders of the company of approximately RMB 389.49 million.

Tong Ren Tang Technologies Co. Ltd. to Report Q3, 2014 Results on Oct 30, 2014

Tong Ren Tang Technologies Co. Ltd. announced that they will report Q3, 2014 results on Oct 30, 2014

Beijing Tong Ren Tang Chinese Medicine Company Limited Announces the Existing Exclusive Distributorship Framework Agreements with Tong Ren Tang Technologies and Tong Ren Tang Ltd

Beijing Tong Ren Tang Chinese Medicine Company Limited announced that the existing exclusive distributorship framework agreements with Tong Ren Tang Technologies and Tong Ren Tang Ltd. The Group is the primary overseas distribution platform of the Parent Group and is the member of the Parent Group solely distributing PRC manufactured Tong Ren Tang branded Chinese medicine products outside PRC. As already indicated in the Prospectus, the parties intend to renew the exclusive distributorship framework agreements upon their expiry subject to all relevant approvals requirements. The renewal is to ensure the continuity of the exclusive distributorship arrangement outside PRC, which is of utmost importance to the Parent Group as well as the Group. As the existing exclusive distributorship framework agreements will soon expire on 31 December 2014, the company entered into the Exclusive Distributorship Framework Agreements with each of Tong Ren Tang Technologies and Tong Ren Tang Ltd. for a further term of three years. The Company also resolved to obtain the new annual caps for the transactions contemplated under the Exclusive Distributorship Framework Agreements for the three years ending 31 December 2017 in order to comply with Rule 20.36 of the GEM Listing Rules.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TGRNF:US $1.14 USD 0.00

TGRNF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TGRNF.
View Industry Companies
 

Industry Analysis

TGRNF

Industry Average

Valuation TGRNF Industry Range
Price/Earnings 22.7x
Price/Sales 3.1x
Price/Book 2.9x
Price/Cash Flow 23.0x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TONG REN TANG TECHNOLOGIES-H, please visit www.tongrentangkj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.